Taurus Endoscopy raises €2.5M seed to advance endoluminal closure

Reading time: ( Word count: )

Taurus Endoscopy, an IHU spin-off specializing in innovative solutions for unmet needs in flexible digestive endoscopy, announces that it has raised €2.5M in venture capital from the French fund MEDEVICE Capital and the U.S. fund Santé Ventures.

Taurus Endoscopy develops solutions for bleeding and flexible endoscopic gastrointestinal closure. At the heart of the technology is an implantable clip with an innovative design resulting from work carried out by the IHU Strasbourg innovation team. “This fundraising will allow Taurus Endoscopy to bring its first product, Taurus 1, to the market and to continue the development of pipeline products for closure in endoluminal interventions. At MEDEVICE, we are convinced that Taurus will be able to bring significant innovation to the market of endoscopic clips, therefore enhancing patient outcomes for the growing number of surgical procedures it addresses” said Cécile Real, Co-founder and CEO of MEDEVICE Capital.

The company was also a 2023 Grand Prix winner of the French national i-Lab competition, organized by the Ministry of Higher Education, Research and Innovation in partnership with BPI France.

Similar articles